Zobrazit více v PubMed
Bassilana F., Nash M., Ludwig M.G. Adhesion G protein-coupled receptors: Opportunities for drug discovery. Nat. Rev. Drug Discov. 2019;18:869–884. doi: 10.1038/s41573-019-0039-y.
PubMed
DOI
Weston M.D., Luijendijk M.W., Humphrey K.D., Moller C., Kimberling W.J. Mutations in the VLGR1 gene implicate G-protein signaling in the pathogenesis of Usher syndrome type II. Am. J. Hum. Genet. 2004;74:357–366. doi: 10.1086/381685.
PubMed
DOI
PMC
Piao X., Hill R.S., Bodell A., Chang B.S., Basel-Vanagaite L., Straussberg R., Dobyns W.B., Qasrawi B., Winter R.M., Innes A.M., et al. G protein-coupled receptor-dependent development of human frontal cortex. Science. 2004;303:2033–2036. doi: 10.1126/science.1092780.
PubMed
DOI
Boyden S.E., Desai A., Cruse G., Young M.L., Bolan H.C., Scott L.M., Eisch A.R., Long R.D., Lee C.C., Satorius C.L., et al. Vibratory Urticaria Associated with a Missense Variant in ADGRE2. N. Engl. J. Med. 2016;374:656–663. doi: 10.1056/NEJMoa1500611.
PubMed
DOI
PMC
Lala T., Hall R.A. Adhesion G protein-coupled receptors: Structure, signaling, physiology, and pathophysiology. Physiol. Rev. 2022;102:1587–1624. doi: 10.1152/physrev.00027.2021.
PubMed
DOI
PMC
Liebscher I., Cevheroglu O., Hsiao C.C., Maia A.F., Schihada H., Scholz N., Soave M., Spiess K., Trajkovic K., Kosloff M., et al. A guide to adhesion GPCR research. FEBS J. 2022;289:7610–7630. doi: 10.1111/febs.16258.
PubMed
DOI
Lin H.H., Hsiao C.C., Pabst C., Hebert J., Schoneberg T., Hamann J. Adhesion GPCRs in Regulating Immune Responses and Inflammation. Adv. Immunol. 2017;136:163–201. doi: 10.1016/bs.ai.2017.05.005.
PubMed
DOI
Sreepada A., Tiwari M., Pal K. Adhesion G protein-coupled receptor gluing action guides tissue development and disease. J. Mol. Med. 2022;100:1355–1372. doi: 10.1007/s00109-022-02240-0.
PubMed
DOI
Tseng W.Y., Stacey M., Lin H.H. Role of Adhesion G Protein-Coupled Receptors in Immune Dysfunction and Disorder. Int. J. Mol. Sci. 2023;24:5499. doi: 10.3390/ijms24065499.
PubMed
DOI
PMC
Brelot A., Chakrabarti L.A. CCR5 Revisited: How Mechanisms of HIV Entry Govern AIDS Pathogenesis. J. Mol. Biol. 2018;430:2557–2589. doi: 10.1016/j.jmb.2018.06.027.
PubMed
DOI
Sodhi A., Montaner S., Gutkind J.S. Viral hijacking of G-protein-coupled-receptor signalling networks. Nat. Rev. Mol. Cell Biol. 2004;5:998–1012. doi: 10.1038/nrm1529.
PubMed
DOI
Maginnis M.S. Virus-Receptor Interactions: The Key to Cellular Invasion. J. Mol. Biol. 2018;430:2590–2611. doi: 10.1016/j.jmb.2018.06.024.
PubMed
DOI
PMC
Cheng H., Lear-Rooney C.M., Johansen L., Varhegyi E., Chen Z.W., Olinger G.G., Rong L. Inhibition of Ebola and Marburg Virus Entry by G Protein-Coupled Receptor Antagonists. J. Virol. 2015;89:9932–9938. doi: 10.1128/JVI.01337-15.
PubMed
DOI
PMC
Margulies B.J., Browne H., Gibson W. Identification of the human cytomegalovirus G protein-coupled receptor homologue encoded by UL33 in infected cells and enveloped virus particles. Virology. 1996;225:111–125. doi: 10.1006/viro.1996.0579.
PubMed
DOI
PMC
Arvanitakis L., Geras-Raaka E., Varma A., Gershengorn M.C., Cesarman E. Human herpesvirus KSHV encodes a constitutively active G-protein-coupled receptor linked to cell proliferation. Nature. 1997;385:347–350. doi: 10.1038/385347a0.
PubMed
DOI
Isegawa Y., Ping Z., Nakano K., Sugimoto N., Yamanishi K. Human herpesvirus 6 open reading frame U12 encodes a functional beta-chemokine receptor. J. Virol. 1998;72:6104–6112. doi: 10.1128/JVI.72.7.6104-6112.1998.
PubMed
DOI
PMC
Nakano K., Tadagaki K., Isegawa Y., Aye M.M., Zou P., Yamanishi K. Human herpesvirus 7 open reading frame U12 encodes a functional beta-chemokine receptor. J. Virol. 2003;77:8108–8115. doi: 10.1128/jvi.77.14.8108-8115.2003.
PubMed
DOI
PMC
Paulsen S.J., Rosenkilde M.M., Eugen-Olsen J., Kledal T.N. Epstein-Barr virus-encoded BILF1 is a constitutively active G protein-coupled receptor. J. Virol. 2005;79:536–546. doi: 10.1128/JVI.79.1.536-546.2005.
PubMed
DOI
PMC
Billstrom M.A., Johnson G.L., Avdi N.J., Worthen G.S. Intracellular signaling by the chemokine receptor US28 during human cytomegalovirus infection. J. Virol. 1998;72:5535–5544. doi: 10.1128/JVI.72.7.5535-5544.1998.
PubMed
DOI
PMC
Casarosa P., Bakker R.A., Verzijl D., Navis M., Timmerman H., Leurs R., Smit M.J. Constitutive signaling of the human cytomegalovirus-encoded chemokine receptor US28. J. Biol. Chem. 2001;276:1133–1137. doi: 10.1074/jbc.M008965200.
PubMed
DOI
Fares S., Spiess K., Olesen E.T.B., Zuo J., Jackson S., Kledal T.N., Wills M.R., Rosenkilde M.M. Distinct Roles of Extracellular Domains in the Epstein-Barr Virus-Encoded BILF1 Receptor for Signaling and Major Histocompatibility Complex Class I Downregulation. mBio. 2019;10:e01707–e01718. doi: 10.1128/mBio.01707-18.
PubMed
DOI
PMC
Guo H.G., Sadowska M., Reid W., Tschachler E., Hayward G., Reitz M. Kaposi’s sarcoma-like tumors in a human herpesvirus 8 ORF74 transgenic mouse. J. Virol. 2003;77:2631–2639. doi: 10.1128/jvi.77.4.2631-2639.2003.
PubMed
DOI
PMC
Maussang D., Verzijl D., van Walsum M., Leurs R., Holl J., Pleskoff O., Michel D., van Dongen G.A., Smit M.J. Human cytomegalovirus-encoded chemokine receptor US28 promotes tumorigenesis. Proc. Natl. Acad. Sci. USA. 2006;103:13068–13073. doi: 10.1073/pnas.0604433103.
PubMed
DOI
PMC
Streblow D.N., Soderberg-Naucler C., Vieira J., Smith P., Wakabayashi E., Ruchti F., Mattison K., Altschuler Y., Nelson J.A. The human cytomegalovirus chemokine receptor US28 mediates vascular smooth muscle cell migration. Cell. 1999;99:511–520. doi: 10.1016/s0092-8674(00)81539-1.
PubMed
DOI
Zuo J., Currin A., Griffin B.D., Shannon-Lowe C., Thomas W.A., Ressing M.E., Wiertz E.J., Rowe M. The Epstein-Barr virus G-protein-coupled receptor contributes to immune evasion by targeting MHC class I molecules for degradation. PLoS Pathog. 2009;5:e1000255. doi: 10.1371/journal.ppat.1000255.
PubMed
DOI
PMC
Woznik M., Rodner C., Lemon K., Rima B., Mankertz A., Finsterbusch T. Mumps virus small hydrophobic protein targets ataxin-1 ubiquitin-like interacting protein (ubiquilin 4) J. Gen. Virol. 2010;91:2773–2781. doi: 10.1099/vir.0.024638-0.
PubMed
DOI
Peng Y.M., van de Garde M.D., Cheng K.F., Baars P.A., Remmerswaal E.B., van Lier R.A., Mackay C.R., Lin H.H., Hamann J. Specific expression of GPR56 by human cytotoxic lymphocytes. J. Leukoc. Biol. 2011;90:735–740. doi: 10.1189/jlb.0211092.
PubMed
DOI
Wanjalla C.N., McDonnell W.J., Barnett L., Simmons J.D., Furch B.D., Lima M.C., Woodward B.O., Fan R., Fei Y., Baker P.G., et al. Adipose Tissue in Persons With HIV Is Enriched for CD4(+) T Effector Memory and T Effector Memory RA(+) Cells, Which Show Higher CD69 Expression and CD57, CX3CR1, GPR56 Co-expression With Increasing Glucose Intolerance. Front. Immunol. 2019;10:408. doi: 10.3389/fimmu.2019.00408.
PubMed
DOI
PMC
Bayin N.S., Frenster J.D., Kane J.R., Rubenstein J., Modrek A.S., Baitalmal R., Dolgalev I., Rudzenski K., Scarabottolo L., Crespi D., et al. GPR133 (ADGRD1), an adhesion G-protein-coupled receptor, is necessary for glioblastoma growth. Oncogenesis. 2016;5:e263. doi: 10.1038/oncsis.2016.63.
PubMed
DOI
PMC
Frenster J.D., Erdjument-Bromage H., Stephan G., Ravn-Boess N., Wang S., Liu W., Bready D., Wilcox J., Kieslich B., Jankovic M., et al. PTK7 is a positive allosteric modulator of GPR133 signaling in glioblastoma. Cell Rep. 2023;42:112679. doi: 10.1016/j.celrep.2023.112679.
PubMed
DOI
PMC
Frenster J.D., Kader M., Kamen S., Sun J., Chiriboga L., Serrano J., Bready D., Golub D., Ravn-Boess N., Stephan G., et al. Expression profiling of the adhesion G protein-coupled receptor GPR133 (ADGRD1) in glioma subtypes. Neurooncol Adv. 2020;2:vdaa053. doi: 10.1093/noajnl/vdaa053.
PubMed
DOI
PMC
Bohnekamp J., Schoneberg T. Cell adhesion receptor GPR133 couples to Gs protein. J. Biol. Chem. 2011;286:41912–41916. doi: 10.1074/jbc.C111.265934.
PubMed
DOI
PMC
Gupte J., Swaminath G., Danao J., Tian H., Li Y., Wu X. Signaling property study of adhesion G-protein-coupled receptors. FEBS Lett. 2012;586:1214–1219. doi: 10.1016/j.febslet.2012.03.014.
PubMed
DOI
Liebscher I., Schon J., Petersen S.C., Fischer L., Auerbach N., Demberg L.M., Mogha A., Coster M., Simon K.U., Rothemund S., et al. A tethered agonist within the ectodomain activates the adhesion G protein-coupled receptors GPR126 and GPR133. Cell Rep. 2014;9:2018–2026. doi: 10.1016/j.celrep.2014.11.036.
PubMed
DOI
PMC
Stephan G., Frenster J.D., Liebscher I., Placantonakis D.G. Activation of the adhesion G protein-coupled receptor GPR133 by antibodies targeting its N-terminus. J. Biol. Chem. 2022;298:101949. doi: 10.1016/j.jbc.2022.101949.
PubMed
DOI
PMC
Lei P., Wang H., Yu L., Xu C., Sun H., Lyu Y., Li L., Zhang D.L. A correlation study of adhesion G protein-coupled receptors as potential therapeutic targets in Uterine Corpus Endometrial cancer. Int. Immunopharmacol. 2022;108:108743. doi: 10.1016/j.intimp.2022.108743.
PubMed
DOI
Meng D., Liu T., Ma F., Wang M. Screening the key genes of prognostic value in the microenvironment for head and neck squamous cell carcinoma. Medicine. 2021;100:e24184. doi: 10.1097/MD.0000000000024184.
PubMed
DOI
PMC
Singh Y., Subbarao N., Jaimini A., Hathaway Q.A., Kunovac A., Erickson B., Swarup V., Singh H.N. Genome-wide expression reveals potential biomarkers in breast cancer bone metastasis. J. Integr. Bioinform. 2022;19:20210041. doi: 10.1515/jib-2021-0041.
PubMed
DOI
PMC
Cui J., Li F., Shi Z.L. Origin and evolution of pathogenic coronaviruses. Nat. Rev. Microbiol. 2019;17:181–192. doi: 10.1038/s41579-018-0118-9.
PubMed
DOI
PMC
Hu B., Guo H., Zhou P., Shi Z.L. Characteristics of SARS-CoV-2 and COVID-19. Nat. Rev. Microbiol. 2021;19:141–154. doi: 10.1038/s41579-020-00459-7.
PubMed
DOI
PMC
Millet J.K., Whittaker G.R. Physiological and molecular triggers for SARS-CoV membrane fusion and entry into host cells. Virology. 2018;517:3–8. doi: 10.1016/j.virol.2017.12.015.
PubMed
DOI
PMC
Tang T., Bidon M., Jaimes J.A., Whittaker G.R., Daniel S. Coronavirus membrane fusion mechanism offers a potential target for antiviral development. Antivir. Res. 2020;178:104792. doi: 10.1016/j.antiviral.2020.104792.
PubMed
DOI
PMC
Tortorici M.A., Veesler D. Structural insights into coronavirus entry. Adv. Virus Res. 2019;105:93–116. doi: 10.1016/bs.aivir.2019.08.002.
PubMed
DOI
PMC
Wang H., Yang P., Liu K., Guo F., Zhang Y., Zhang G., Jiang C. SARS coronavirus entry into host cells through a novel clathrin- and caveolae-independent endocytic pathway. Cell Res. 2008;18:290–301. doi: 10.1038/cr.2008.15.
PubMed
DOI
PMC
Clausen T.M., Sandoval D.R., Spliid C.B., Pihl J., Perrett H.R., Painter C.D., Narayanan A., Majowicz S.A., Kwong E.M., McVicar R.N., et al. SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2. Cell. 2020;183:1043–1057. doi: 10.1016/j.cell.2020.09.033.
PubMed
DOI
PMC
Walls A.C., Park Y.J., Tortorici M.A., Wall A., McGuire A.T., Veesler D. Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein. Cell. 2020;181:281–292.e6. doi: 10.1016/j.cell.2020.02.058.
PubMed
DOI
PMC
Hoffmann M., Kleine-Weber H., Schroeder S., Kruger N., Herrler T., Erichsen S., Schiergens T.S., Herrler G., Wu N.H., Nitsche A., et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020;181:271–280. doi: 10.1016/j.cell.2020.02.052.
PubMed
DOI
PMC
Belouzard S., Millet J.K., Licitra B.N., Whittaker G.R. Mechanisms of coronavirus cell entry mediated by the viral spike protein. Viruses. 2012;4:1011–1033. doi: 10.3390/v4061011.
PubMed
DOI
PMC
Duan L., Zheng Q., Zhang H., Niu Y., Lou Y., Wang H. The SARS-CoV-2 Spike Glycoprotein Biosynthesis, Structure, Function, and Antigenicity: Implications for the Design of Spike-Based Vaccine Immunogens. Front. Immunol. 2020;11:576622. doi: 10.3389/fimmu.2020.576622.
PubMed
DOI
PMC
Abdel Hameid R., Cormet-Boyaka E., Kuebler W.M., Uddin M., Berdiev B.K. SARS-CoV-2 may hijack GPCR signaling pathways to dysregulate lung ion and fluid transport. Am. J. Physiol. Lung Cell Mol. Physiol. 2021;320:L430–L435. doi: 10.1152/ajplung.00499.2020.
PubMed
DOI
PMC
Singh Y., Gupta G., Satija S., Pabreja K., Chellappan D.K., Dua K. COVID-19 transmission through host cell directed network of GPCR. Drug Dev. Res. 2020;81:647–649. doi: 10.1002/ddr.21674.
PubMed
DOI
PMC
Vankova E., Kasparova P., Khun J., Machkova A., Julak J., Slama M., Hodek J., Ulrychova L., Weber J., Obrova K., et al. Polylactic acid as a suitable material for 3D printing of protective masks in times of COVID-19 pandemic. PeerJ. 2020;8:e10259. doi: 10.7717/peerj.10259.
PubMed
DOI
PMC
Reed L.J., Muench H. A simple method of estimating fifty percent endpoints. Am. J. Hyg. 1938;27:493–497.
Hejdankova Z., Vanek V., Sedlak F., Prochazka J., Diederichs A., Kereïche S., Novotna B., Budesinsky M., Birkus G., Grantz Saskova K., et al. Lipid Nanoparticles for Broad-Spectrum Nucleic Acid Delivery. Adv. Funct. Mater. 2021;31:2101391. doi: 10.1002/adfm.202101391.
DOI
Vandesompele J., De Preter K., Pattyn F., Poppe B., Van Roy N., De Paepe A., Speleman F. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002;3:RESEARCH0034. doi: 10.1186/gb-2002-3-7-research0034.
PubMed
DOI
PMC
Radonic A., Thulke S., Bae H.G., Muller M.A., Siegert W., Nitsche A. Reference gene selection for quantitative real-time PCR analysis in virus infected cells: SARS corona virus, Yellow fever virus, Human Herpesvirus-6, Camelpox virus and Cytomegalovirus infections. Virol. J. 2005;2:7. doi: 10.1186/1743-422X-2-7.
PubMed
DOI
PMC
Bouhaddou M., Reuschl A.K., Polacco B.J., Thorne L.G., Ummadi M.R., Ye C., Rosales R., Pelin A., Batra J., Jang G.M., et al. SARS-CoV-2 variants evolve convergent strategies to remodel the host response. Cell. 2023;186:4597–4614. doi: 10.1016/j.cell.2023.08.026.
PubMed
DOI
PMC
Wyler E., Mosbauer K., Franke V., Diag A., Gottula L.T., Arsie R., Klironomos F., Koppstein D., Honzke K., Ayoub S., et al. Transcriptomic profiling of SARS-CoV-2 infected human cell lines identifies HSP90 as target for COVID-19 therapy. iScience. 2021;24:102151. doi: 10.1016/j.isci.2021.102151.
PubMed
DOI
PMC
Mali S.S., Silva R., Gong Z., Cronce M., Vo U., Vuong C., Moayedi Y., Cox J.S., Bautista D.M. SARS-CoV-2 papain-like protease activates nociceptors to drive sneeze and pain. bioRxiv. 2024 doi: 10.1101/2024.01.10.575114.
DOI
Ni Y.Y., Chen Y., Lu S.Y., Sun B.Y., Wang F., Wu X.L., Dang S.Y., Zhang G.H., Zhang H.X., Kuang Y., et al. Deletion of Gpr128 results in weight loss and increased intestinal contraction frequency. World J. Gastroenterol. 2014;20:498–508. doi: 10.3748/wjg.v20.i2.498.
PubMed
DOI
PMC
Chen T.H., Hsu M.T., Lee M.Y., Chou C.K. Gastrointestinal Involvement in SARS-CoV-2 Infection. Viruses. 2022;14:1188. doi: 10.3390/v14061188.
PubMed
DOI
PMC
Grieb P., Swiatkiewicz M., Prus K., Rejdak K. Hypoxia may be a determinative factor in COVID-19 progression. Curr. Res. Pharmacol. Drug Discov. 2021;2:100030. doi: 10.1016/j.crphar.2021.100030.
PubMed
DOI
PMC
Kashani K.B. Hypoxia in COVID-19: Sign of Severity or Cause for Poor Outcomes. Mayo Clin. Proc. 2020;95:1094–1096. doi: 10.1016/j.mayocp.2020.04.021.
PubMed
DOI
PMC
Frenster J.D., Inocencio J.F., Xu Z., Dhaliwal J., Alghamdi A., Zagzag D., Bayin N.S., Placantonakis D.G. GPR133 Promotes Glioblastoma Growth in Hypoxia. Neurosurgery. 2017;64:177–181. doi: 10.1093/neuros/nyx227.
PubMed
DOI
PMC
Jana S., Heaven M.R., Stauft C.B., Wang T.T., Williams M.C., D’Agnillo F., Alayash A.I. HIF-1alpha-Dependent Metabolic Reprogramming, Oxidative Stress, and Bioenergetic Dysfunction in SARS-CoV-2-Infected Hamsters. Int. J. Mol. Sci. 2022;24:558. doi: 10.3390/ijms24010558.
PubMed
DOI
PMC
Cong Y., Ren X. Coronavirus entry and release in polarized epithelial cells: A review. Rev. Med. Virol. 2014;24:308–315. doi: 10.1002/rmv.1792.
PubMed
DOI
PMC